Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
J Pediatr ; 130(5): 825-8, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9152296

RESUMO

A 2-month-old child with infantile hypophosphatasia had hypercalcemia (3.49 mmol/L (14 mg/dl)), nephrocalcinosis, and diminished bone mineral content. Hypercalcemia was corrected with calcitonin. Hypercalciuria and bone demineralization abated with chlorothiazide. Hypercalcemia is hypothesized to be related to normal bone resorption in conjunction with impaired bone mineralization. Chlorothiazide may alleviate this impairment.


Assuntos
Reabsorção Óssea/tratamento farmacológico , Calcitonina/uso terapêutico , Clorotiazida/uso terapêutico , Hipofosfatasia/tratamento farmacológico , Inibidores de Simportadores de Cloreto de Sódio/uso terapêutico , Cálcio/urina , Diuréticos , Feminino , Humanos , Hipercalcemia/prevenção & controle , Hipofosfatasia/complicações , Hipofosfatasia/metabolismo , Lactente , Nefrocalcinose/complicações , Nefrocalcinose/tratamento farmacológico , Nefrocalcinose/metabolismo
4.
J Pediatr ; 129(2): s13-8, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8765644

RESUMO

1. The best way to prevent early growth failure in children with renal disease is by the use of specified nutrition and appropriate buffer, activated vitamin D, and calcium-containing phosphate binders as needed. With prenatal diagnosis of anatomically abnormal kidneys available, this type of early intervention may be much more feasible in the 1990s. 2. Supplemental sodium and water in children with polyuria and intravascular volume depletion may prevent growth failure. Cow milk is detrimental in this group of individuals because of high solute and protein load, often causing intravascular volume depletion, hyperphosphatemia, and acidosis. 3. Children with acquired glomerular disease may need sodium restriction and, if treated with steroids, a diet low in saturated fat. 4. Children with nephrotic syndrome and severe edema should be evaluated for malabsorption and subsequent malnutrition. Protein intake should be supplemented only at the RDA and to replace ongoing losses. Long-term sodium restriction is appropriate. Hyperlipidemia should be monitored: if nephrosis is chronic, a low saturated fat diet should be instituted. Angiotensin-converting enzyme inhibitors can decrease urinary protein loss and may ameliorate hyperlipidemia. Children resistant to therapy can have very high morbidity. 5. Children with <50 % of normal creatinine clearance should have PTH measured and activated vitamin D therapy should be started if PTH is elevated more than two to three times normal. Thereafter careful monitoring of calcium, phosphorus, and PTH is crucial to prevent renal osteodystrophy, low turnover bone disease, and hypercalcemia with hypercalciuria and nephrocalcinosis. 6. Children with tubular defects with severe polyuria also may benefit from low-solute, high-volume feedings. 7. All physicians caring for children with renal disease should have pediatric nephrology consultation available. Prevention of growth failure is much more cost effective than pharmacologic therapy. Before initiating growth hormone treatment for growth retardation, assiduous treatment of co-existing renal osteodystrophy and provision of optimal nutritional intake should be accomplished.


Assuntos
Falência Renal Crônica/terapia , Fenômenos Fisiológicos da Nutrição , Cálcio/uso terapêutico , Criança , Creatinina/urina , Dieta , Hidratação , Transtornos do Crescimento/prevenção & controle , Humanos , Falência Renal Crônica/tratamento farmacológico , Síndrome Nefrótica/tratamento farmacológico , Síndrome Nefrótica/terapia , Hormônio Paratireóideo/sangue , Sódio/uso terapêutico , Vitamina D/uso terapêutico
5.
J Pediatr ; 124(4): 520-8, 1994 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8151464

RESUMO

Because controlled trials in adults have shown accelerated deterioration of renal function in a small number of patients receiving calcitriol for renal osteodystrophy, we initiated a prospective, randomized, double-blind study of the use of calcitriol versus dihydrotachysterol in children with chronic renal insufficiency. We studied children aged 1 1/2 through 10 years, with a calculated glomerular filtration rate between 20 and 75 ml/min per 1.73 m2, and with elevated serum parathyroid hormone concentrations. Ninety-four patients completed a mean of 8.0 months of control observations and were randomly assigned to a treatment period; 82 completed the treatment period of at least 6 months while receiving a calcitriol dosage (mean +/- SD) of 17.1 +/- 5.9 ng/kg per day or a dihydrotachysterol dosage of 13.8 +/- 3.3 micrograms/kg per day. With treatment the height z scores for both calcitriol- and dihydrotachysterol-treated groups showed no differences between the two groups. In relation to cumulative dose, there was a significant decrease in glomerular filtration rate for both calcitriol and dihydrotachysterol; for calcitriol the rate of decline was significantly steeper (p = 0.0026). The treatment groups did not differ significantly with respect to the incidence of hypercalcemia (serum calcium concentration > 2.7 mmol/L (> 11 mg/dl)). We conclude that careful follow-up of renal function is mandatory during the use of either calcitriol or dihydrotachysterol because both agents were associated with significant declines in renal function. There was no significant difference between calcitriol and dihydrotachysterol in promoting linear growth or causing hypercalcemia in children with chronic renal insufficiency. Dihydrotachysterol, the less costly agent, can be used with equal efficacy.


Assuntos
Calcitriol/uso terapêutico , Di-Hidrotaquisterol/uso terapêutico , Transtornos do Crescimento/tratamento farmacológico , Falência Renal Crônica/complicações , Calcitriol/farmacologia , Criança , Pré-Escolar , Di-Hidrotaquisterol/farmacologia , Método Duplo-Cego , Feminino , Taxa de Filtração Glomerular/efeitos dos fármacos , Transtornos do Crescimento/etiologia , Humanos , Hipercalcemia/etiologia , Lactente , Masculino , Estudos Prospectivos , Resultado do Tratamento
6.
J Pediatr ; 122(6): S68-73, 1993 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8501551

RESUMO

The kidney has been implicated as both an etiologic factor and as a target organ in patients with essential hypertension. Renal function has not been studied extensively in children and adolescents with essential hypertension. Eighty-eight subjects, aged 6 to 23 years, with blood pressure persistently above the 90th percentile for age were studied. Creatinine clearance was determined from a single 24-hour urine collection. The mean creatinine clearance was 129.3 +/- 55.3 ml/min per 1.73 m2. Multiple regression analysis was used to investigate potential correlates of creatinine clearance. Because creatinine clearance was not normally distributed, the logarithm of creatinine clearance was used as the dependent variable. Body mass index, resting heart rate, and basal supine plasma renin activity were significant direct independent correlates. Peripheral vascular resistance at maximal exercise was an inverse correlate of the logarithm of creatinine clearance. These findings are consistent with previous studies of adults and may provide the basis for strategies to identify young patients with essential hypertension who are at risk for the development of renal dysfunction.


Assuntos
Creatina/metabolismo , Hipertensão/fisiopatologia , Rim/fisiopatologia , Adolescente , Adulto , Pressão Sanguínea , Constituição Corporal , Criança , Feminino , Taxa de Filtração Glomerular , Humanos , Masculino , Análise de Regressão , Renina/sangue
7.
J Pediatr ; 122(1): 60-5, 1993 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8419615

RESUMO

We determined the prevalence and clinical features of rate-dependent distal renal tubular acidosis (dRTA) in 31 children examined for possible renal tubular acidosis by measuring the urinary-minus-blood partial pressure of carbon dioxide (U-B PCO2) gradient, minimal urinary pH, and fractional excretion of bicarbonate. Of 20 patients with low U-B PCO2 gradients, nine could not lower urinary pH < or = 5.5, indicating classic dRTA, whereas 11 could lower urinary pH < or = 5.5, as described in rate-dependent dRTA. When patients with rate-dependent dRTA and classic (type I) dRTA were compared, there was no difference in the mean U-B PCO2 gradient or in clinical findings, including age, reason for referral, presence of nephrocalcinosis, or depression of linear growth. We conclude that children with rate-dependent dRTA are susceptible to at least some of the same sequelae as children with classic dRTA. Measurement of minimal urinary pH will not detect this subtle form of dRTA. Determination of the U-B PCO2 gradient should be considered a routine part of evaluation for suspected renal tubular acidosis in a child.


Assuntos
Acidose Tubular Renal/classificação , Dióxido de Carbono/sangue , Dióxido de Carbono/urina , Acidose Tubular Renal/sangue , Acidose Tubular Renal/fisiopatologia , Acidose Tubular Renal/urina , Bicarbonatos/urina , Pré-Escolar , Creatinina/sangue , Diagnóstico Diferencial , Eletrólitos/sangue , Crescimento/fisiologia , Humanos , Concentração de Íons de Hidrogênio , Lactente , Pressão Parcial , Estudos Prospectivos
8.
J Pediatr ; 116(5): S98-102, 1990 May.
Artigo em Inglês | MEDLINE | ID: mdl-2329415

RESUMO

With the exception of C3 nephritic factor, autoantibody formation has not been commonly associated with membranoproliferative nephritis (MPGN). We measured autoantibodies (nephritic factors) to the C3 convertases C3bBb (NFa) and C3bBbP (NFt), which result in fast and slow C3 activation, respectively, and to a neoantigen on C1q fixed to a solid phase (spC1q) in sera from 29 patients with MPGN type I, 26 with type II, and 28 with type III. Autoantibody formation was common in all MPGN types. An autoantibody to a C3 convertase neoantigen was identified in more than 75% of the hypocomplementemic MPGN sera tested. Anti-C3bBb (NFa) was present in 81% of patients with MPGN type II but was rarely found in either type I or type III. Anti-C3bBbP (NFt) was common in both MPGN I and III. Anti-spC1q was present in 74% of patients with type I and in 38% and 48% of types II and III MPGN, respectively. Patients with MPGN types I, II, and III had one and two serum autoantibodies detected significantly more frequently than did a group of healthy subjects. The presence of any one autoantibody was not specifically associated with the presence of any other autoantibody. The results indicate that multiple autoantibody formation is common in all MPGN types. MPGN II, and possibly MPGN I, tend to form more specific autoantibodies.


Assuntos
Autoanticorpos/análise , Enzimas Ativadoras do Complemento/imunologia , Convertases de Complemento C3-C5/imunologia , Glomerulonefrite Membranoproliferativa/imunologia , Complexo Antígeno-Anticorpo/análise , Sangue , Ativação do Complemento/imunologia , Complemento C1q/imunologia , Fator Nefrítico do Complemento 3/imunologia , Fator B do Complemento/imunologia , Glomerulonefrite Membranoproliferativa/classificação , Humanos , Rim/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA